Newspapers / Q-notes (Charlotte, N.C.) / April 17, 1999, edition 1 / Page 9
Part of Q-notes (Charlotte, N.C.) / About this page
This page has errors
The date, title, or page description is wrong
This page has harmful content
This page contains sensitive or offensive material
IS HIV-RELATED WEIGHT LOSS SAPPING YOUR STRENGTH? 3>isSi i i GAIN WEIGHT. INCREASE LEAN BODY MASS. WORKOUT. EAT RIGHT. FEEL GREAT! Ask your doctor about OXANDRIN, the only oral anabolic agent approved to help promote weight gain after involuntaiy weight loss. Studies' ’ have shown that OXANDRIN increases body weight and, when combined with resistance exercise, can build beneficial lean body mass and physical strength.' And people who gain weight while taking OXANDRIN have also reported a better appetite and sense of well-being.''^ That’s the right stuff. OXANDRIN. It may help you feel like yourself again. Please visit us at our Web site, www.oxandrin.com, or coll 800-741-2698. NDRIN ;usp(! 2.S mg tablets THE RIGHT STUFF OXANDRIN (oxandrolonB, USP) ClllPackage Insert: In patients receiving androgenic anabolic steroid therapy, 1) peliosis hepatis a condition in w/hich the liver and sometimes splenic tissue is replaced with blood-filled cysts, has been reported; 2) liver cell tumors are also reported; 3) blood lipid changes that are known to be associated with increased risk of atherosclerosis are seen. See Warnings and Precautions sections of complete prescribing information. ^ ^ Contraindications: 1) known or suspected carcinoma of the prostate or the male breast; 2) carcinoma of the breast in females with hypercalcemia (androgenic anabolic steroids may stimulate osteolytic bone resorp ion); 3) pregnancy, because of possible masculinization of the fetus. Oxandrin has been shown to cause embtyotoxicity fetotoxicity infertility, and masculinization of female animal offspring when given in doses 9 times the human dose; 4) nephrosis, the nephrotic phase of nephritis; 5) hypercalcemia.^’ Barbieri T, Van Loan M, et al. The effects‘of oxandrolone plus resistance exercise on nitrogen balance, body composition and strength in men with AIDS wasting syndrorne. Preserited at. 12th World AIDS Conference; June 28-July 3,1998; Geneva, Switzerland. Abstract. 2. Fisher A, Abbaticola M, the Oxandrolone effects of oxandrolone on body weight and composition in patients with HIV-associated weight loss. Presented at: 5th Conference on Retroviruses and Opportunistic Infections, February 1-5,1998, Chicago, III. Abstract. 3. Berger JR, Pall L, Hall CD, et al. Oxandrolone in AIDS-wasting myopathy. AIDS. 1996;10:1657-1662. 0XA-7379T February 1999 ©1999 BTG Pharmaceuticals. Please see full prescribing information on the following page.
Q-notes (Charlotte, N.C.)
Standardized title groups preceding, succeeding, and alternate titles together.
April 17, 1999, edition 1
9
Click "Submit" to request a review of this page. NCDHC staff will check .
0 / 75